pharmaceuticals

It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.

As national distributors and pharmacies restricted the flow of painkillers in response to the opioid crisis, Florida’s most popular grocer did the opposite, according to a Tampa Bay Times data analysis.

It's our monthly medical roundtable, when we dive into the month's most significant health headlines.

Florida Hospital Association president Mary Mayhew tells "The Florida Roundup" that she hopes people can start benefitting from the program within the year.

The FDA said Florida’s program will be authorized for two years. Approval comes after months of wrangling that led to the state filing two lawsuits against the agency.

A national shortage of Adderall is affecting more than just ADHD patients. Those with narcolepsy, a much rarer condition, are often treated with the medication. Without it, they're often unable to drive or function as usual.

Under the agreement, McKinsey must establish a fund to reimburse insurers, private benefit plans and others for some or all of their prescription opioid costs.

Hospitals rely on scores of generic drugs given by injection. But these workhorses are often in short supply. Cheap prices have led to factory closures that leave the supply chain vulnerable.

AHCA Secretary Jason Weida told a state House panel he is “cautiously optimistic” the FDA will approve the plan, which the state has been pursuing since 2019.

The White House unveiled a list of 48 drugs whose prices increased faster than the rate of inflation this year. Under a new law, drugmakers must pay rebates to the government because of it.